Last $10.25 USD
Change Today +0.25 / 2.50%
Volume 5.6K
LLTP On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mary K. Pendergast J.D., L.L.M.

Chair of Advisory Board and Advisor of Regulatory & Strategic Matters, Lightlake Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 63 board members in 5 different organizations across 6 different industries.

See Board Relationships
63--

Background*

Ms. Mary K. Pendergast, J.D., L.L.M., has been the President of Pendergast Consulting since September 2003. Ms. Pendergast serves as Chair of Advisory Board at Lightlake Therapeutics Inc. Ms. Pendergast has been Advisor of Regulatory and Strategic Matters at Lightlake Therapeutics Inc. since December 29, 2010. She served as an Executive Vice President of Government Affairs of Elan Corporation from January 1998 to December 2003. She served as Deputy Commissioner and Senior ...

Read Full Background

Corporate Headquarters*

96-98 Baker Street
London, Greater London W1U 6TJ

United Kingdom

Phone: 44 20 3617 8739
Fax: 44 20 7034 1943

Board Members Memberships*

Independent Director
2002-N/A
Former Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
2002-2011
Former Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
2013-Present
Independent Director and Member of Compliance Committee
2014-Present
Non Executive Director, Member of Compensation & Organization Committee and Member of Quality Committee

Education*

BA 1972
Northwestern University
Master's Degree 1977
Yale Law School
JD 1976
University Of Iowa College Of Law

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LLTP:US $10.25 USD +0.25

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Josef H. von Rickenbach Founder, Chairman and Chief Executive Officer
PAREXEL International Corporation
$883.3K
James C. Foster J.D.Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Strategic Planning & Capital Allocation Committee
Charles River Laboratories International, Inc.
$1.1M
Ge Li Ph.D.Co-Founder, Chairman, Chief Executive Officer, Member of Strategy & Finance Committee and Member of Corporate Governance & Nominations Committee
WuXi PharmaTech (Cayman) Inc.
--
Miroslav Reljanovic M.D.Founder, Owner, Chief Executive Officer and Director
Ergomed Plc
38.0K GBP
D. Jamie Macdonald Chief Executive Officer and Director
INC Research Holdings, Inc.
$407.7K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIGHTLAKE THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.